355 resources
By Version
By Authority
By Realm
Prev Rows 200 - 355
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
---|---|---|---|---|---|---|---|---|---|
smart.who.int.immunizations | R4 | Measure/IMMZIND37 | IMMZIND37 | draft | 2025-06 | who | |||
smart.who.int.immunizations | R4 | Measure/IMMZIND38 | IMMZIND38 | draft | 2025-06 | who | |||
smart.who.int.immunizations | R4 | Measure/IMMZIND39 | IMMZIND39 | draft | 2025-06 | who | |||
smart.who.int.immunizations | R4 | Measure/IMMZIND44 | IMMZIND44 | draft | 2025-06 | who | |||
smart.who.int.immunizations | R4 | Measure/IMMZIND45 | IMMZIND45 | draft | 2025-06 | who | |||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS72FHIRSTKAntithromboticDay2 | Antithrombotic Therapy By End of Hospital Day 2FHIR | active | 2025-07 | ||||
example.fhir.uv.mycontentig | R4 | Measure/DischargedonAntithromboticTherapyFHIRExample | Discharged on Antithrombotic Therapy FHIR Example | draft | 2025-08 | uv | hl7 | ||
gov.healthit.ecqi.ecqms.subset | R4 | Measure/DischargedonAntithromboticTherapyFHIR | Discharged on Antithrombotic TherapyFHIR | active | 2024-09 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS104FHIRSTKDCAntithrombotic | Discharged on Antithrombotic TherapyFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS71FHIRSTKAnticoagAFFlutter | Anticoagulation Therapy for Atrial Fibrillation/FlutterFHIR | active | 2025-07 | ||||
hl7.fhir.us.pco | R4 | Measure/GoalIdentificationMeasure | Person-Centered Goal Identification | draft | pc | 2025-02 | us | hl7 | |
hl7.fhir.us.pco | R4 | Measure/GoalFollowUpMeasure | Person-Centered Goal Follow-Up | draft | pc | 2025-02 | us | hl7 | |
hl7.fhir.us.davinci-deqm | R4 | Measure/attestation-boolean-example | Immunization Registry Reporting | active | cqi | 2025-07 | us | hl7 | |
hl7.fhir.us.mihr | R4 | Measure/PIHCohort | PIH Cohort | draft | 2022-11 | us | hl7 | ||
hl7.fhir.us.mihr | R4 | Measure/PAMDeaths | PAMDeaths Cohort | draft | 2022-11 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS0334FHIRPCCesareanBirth | Cesarean BirthFHIR | active | 2025-07 | ||||
smart.who.int.hiv | R4 | Measure/HIVIND44 | HIV.IND.44 TPT initiation | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND28 | HIV.IND.28 Total attrition from ART | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND45 | HIV.IND.45 TPT completion | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND33 | HIV.IND.33 Early viral load testing (at six months) | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND18 | HIV.IND.18 People living with HIV who know their HIV status (first 95) | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND27 | HIV.IND.27 People living with HIV on ART | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND19 | HIV.IND.19 HTS test volume and positivity | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND30 | HIV.IND.30 New ART patients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND5 | HIV.IND.5 Number of PEP recipients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND2 | HIV.IND.2 Total PrEP recipients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND22 | HIV.IND.22 HTS partner services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND93 | HIV.IND.93 Cervical cancer screening | draft | 2024-08 | who | |||
gov.healthit.ecqi.ecqms.subset | R4 | Measure/SevereObstetricComplicationsFHIR | Severe Obstetric ComplicationsFHIR | active | 2024-09 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1028FHIRPCSevereOBComps | Severe Obstetric ComplicationsFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS130FHIRColorectalCancerScreening | Colorectal Cancer ScreeningFHIR | active | 2025-06 | ||||
hl7.fhir.uv.cqm | R4 | Measure/EXM130-FHIR | EXM130 - Colorectal Cancer Screening Measure | active | 2025-08 | uv | hl7 | ||
fhir.cqf.ccc | R4 | Measure/ColorectalCancerScreeningCQM | Colorectal Cancer Screening CQM | draft | 2025-06 | us | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/EXM130-FHIR | EXM130 - Colorectal Cancer Screening Measure | active | 2022-02 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS133FHIRCataracts2040BCVAwithin90Days | Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract SurgeryFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS117FHIRChildhoodImmunizationStatus | Childhood Immunization StatusFHIR | active | 2025-07 | ||||
hl7.fhir.uv.cqm | R4 | Measure/EXM146-FHIR | EXM146 - Appropriate Testing for Children with Pharyngitis | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/EXM146-FHIR | EXM146 - Appropriate Testing for Children with Pharyngitis | active | 2022-02 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS75FHIRChildrenWhoHaveDentalDecayOrCavities | Children Who Have Dental Decay or CavitiesFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms.subset | R4 | Measure/PrimaryCariesPreventionasOfferedbyDentistsFHIR | Primary Caries Prevention Intervention as Offered by DentistsFHIR | active | 2024-09 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS74FHIRPrimaryCariesPreventionasOfferedbyDentists | Primary Caries Prevention Intervention as Offered by DentistsFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS996FHIRAptTxforSTEMI | Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department FHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS22FHIRPCSBPScreeningFollowUp | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up DocumentedFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/OncologyPainIntensityQuantifiedFHIR | Oncology: Medical and Radiation Pain Intensity QuantifiedFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS128FHIRAntidepressantMedManagement | Antidepressant Medication ManagementFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS122FHIRDiabetesAssessGreaterThan9Percent | Diabetes: Glycemic Status Assessment Greater Than 9%FHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS165FHIRControllingHighBloodPressure | Controlling High Blood PressureFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS56FHIRFunctionalStatusAssessmentforTotalHipReplacement | Functional Status Assessment for Total Hip ReplacementFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS155FHIRWeightAssessandCounselforKids | Weight Assessment and Counseling for Nutrition and Physical Activity for Children/AdolescentsFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS2FHIRPCSDepressionScreenAndFollowUp | Preventive Care and Screening: Screening for Depression and Follow-Up PlanFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms.subset | R4 | Measure/HIVScreeningFHIR | HIV ScreeningFHIR | active | 2024-09 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS349FHIRHIVScreening | HIV ScreeningFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS69FHIRPCSBMIScreenAndFollowUp | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up PlanFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS145FHIRCADBetaBlockerTherapyPriorMIorLVSD | Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)FHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS142FHIRDRCommunicationWithPhysicianManagingDiabetes | Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes CareFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS144FHIRHFBetaBlockerTherapyforLVSD | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS135FHIRHFACEIorARBorARNIforLVSD | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS143FHIRPOAGOpticNerveEvaluation | Primary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS645FHIRBoneDensityProstateCancerAndrogenDeprivationTherapy | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation TherapyFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer | Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder CancerFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS771FHIRUrinarySymptomScoreChangeBenignProstaticHyperplasia | Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic HyperplasiaFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS50FHIRCRLReceiptofSpecialistReport | Closing the Referral Loop: Receipt of Specialist ReportFHIR | active | 2025-07 | ||||
example.fhir.uv.mycontentig | R4 | Measure/HIVViralSuppressionFHIRExample | HIV Viral Suppression FHIR Example | draft | 2025-08 | uv | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS149FHIRDementiaCognitiveAssessment | Dementia: Cognitive AssessmentFHIR | active | 2025-07 | ||||
smart.who.int.hiv | R4 | Measure/HIVIND85 | HIV.IND.85 HBsAg positivity, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND86 | HIV.IND.86 HBsAg positivity, HIV-positive clients | draft | 2024-08 | who | |||
smart.who.int.anc | R4 | Measure/ANCIND12 | ANC.IND.12 Percentage of pregnant women counselled and tested for HIV | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND03 | ANC.IND.03 Percentage of pregnant women screened for syphilis during ANC | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND02 | ANC.IND.02 Percentage of pregnant women who received iron and folic acid (IFA) supplements for 90+ days | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND13 | ANC.IND.13 Percentage of pregnant women who received oral pre-exposure prophylaxis (PrEP) | draft | 2025-06 | uv | who | ||
smart.who.int.hiv | R4 | Measure/HIVIND87 | HIV.IND.87 HBsAg positivity, pregnant women | draft | 2024-08 | who | |||
smart.who.int.anc | R4 | Measure/ANCIND05 | ANC.IND.05 Percentage of pregnant women with a minimum of eight antenatal care contacts | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND10 | ANC.IND.10 Percentage of pregnant women with an ultrasound scan before 24 weeks | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND04 | ANC.IND.04 Percentage of pregnant women with at least four ANC contacts | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND07 | ANC.IND.07 Percentage of pregnant women with at least one blood pressure measure during ANC | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND08 | ANC.IND.08 Percentage of pregnant women with at least one blood pressure measure in the third trimester during ANC | draft | 2025-06 | uv | who | ||
hl7.fhir.uv.crmi | R4 | Measure/publishable-example | ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester (Publishable Example) | draft | 2023-03 | uv | hl7 | ||
hl7.fhir.uv.crmi | R4 | Measure/shareable-example | ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester (Shareable Example) | draft | 2023-03 | uv | hl7 | ||
smart.who.int.anc | R4 | Measure/ANCIND01 | ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester | draft | 2025-06 | uv | who | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS68FHIRDocumentationofCurrentMedications | Documentation of Current Medications in the Medical RecordFHIR | active | 2025-07 | ||||
hl7.fhir.uv.cqm | R4 | Measure/EXM124-FHIR | EXM124 - Cervical Cancer Screening | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/EXM124-FHIR | EXM124 - Cervical Cancer Screening | active | 2022-02 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS124FHIRCervicalCancerScreening | Cervical Cancer ScreeningFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS125FHIRBreastCancerScreening | Breast Cancer ScreeningFHIR | active | 2025-06 | ||||
hl7.fhir.uv.cqm | R4 | Measure/EXM125-FHIR | EXM125 - Breast Cancer Screening | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/EXM125-FHIR | EXM125 - Breast Cancer Screening | active | 2022-02 | us | hl7 | ||
smart.who.int.anc | R4 | Measure/ANCIND11 | ANC.IND.11 Percentage of women who received three doses or more of intermittent preventive therapy for malaria (IPTp) during their last pregnancy | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND09 | ANC.IND.09 Percentage of pregnant women whose baby’s heartbeat was listened to at least once during ANC | draft | 2025-06 | uv | who | ||
smart.who.int.anc | R4 | Measure/ANCIND06 | ANC.IND.06 Pregnant women who received counselling on danger signs (%) during at least one ANC contact | draft | 2025-06 | uv | who | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS506FHIRSafeUseofOpioids | Safe Use of Opioids - Concurrent PrescribingFHIR | active | 2025-07 | ||||
hl7.fhir.uv.saner | R4 | Measure/CDCHealthcareSupplyPathway | COVID-19 Healthcare Supply Pathway | draft | 2020-04 | uv | hl7 | ||
hl7.fhir.uv.saner | R4 | Measure/CDCHealthcareWorkerStaffingPathway | COVID-19 Healthcare Worker Staffing Pathway | draft | 2020-04 | uv | hl7 | ||
hl7.fhir.us.nhsn-dqm | R4 | Measure/NHSNdQMAcuteCareHospitalInitialPopulation | NHSN dQM Acute Care Hospital Initial Population | draft | 2024-02 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS832HHAKIFHIR | Hospital Harm - Acute Kidney InjuryFHIR | active | 2025-05 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS816FHIRHHHypo | Hospital Harm - Severe HypoglycemiaFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS826FHIRHHPI | Hospital Harm - Pressure InjuryFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS159FHIRDepressionRemissionatTwelveMonths | Depression Remission at Twelve MonthsFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS146FHIRAppropriateTestingforPharyngitis | Appropriate Testing for PharyngitisFHIR | active | 2025-06 | ||||
hl7.fhir.uv.cqm | R4 | Measure/PreventiveCareandWellnessPatientLevelLinearComposite | Preventive Care and Wellness Patient-level Linear Composite | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessPatientLevelLinearComposite | Preventive Care and Wellness Patient-level Linear Composite | draft | 2024-11 | us | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/PreventiveCareandWellnessWeightedComposite | Preventive Care and Wellness Weighted Composite | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessWeightedComposite | Preventive Care and Wellness Weighted Composite | draft | 2024-11 | us | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/PreventiveCareandWellnessAllOrNothingComposite | Preventive Care and Wellness All-Or-Nothing Composite | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessAllOrNothingComposite | Preventive Care and Wellness All-Or-Nothing Composite | draft | 2024-11 | us | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/PreventiveCareandWellnessOpportunityComposite | Preventive Care and Wellness Opportunity Composite | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessOpportunityComposite | Preventive Care and Wellness Opportunity Composite | draft | 2024-11 | us | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/EXM55-FHIR | EXM55 - Median Emergency Department Visit Duration | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/EXM55-FHIR | EXM55 - Median Emergency Department Visit Duration | active | 2022-02 | us | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/measure-risk-adjustment-FHIR2 | Risk Adjustment FHIR DSTU2 | active | 2019-02 | us | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/Terminology-FHIR | Terminology FHIR | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/Terminology-FHIR | Terminology FHIR | active | 2022-02 | us | hl7 | ||
hl7.fhir.us.davinci-deqm | R4 | Measure/date-of-last-power-outage | Date Of Last Power Outage | active | 2020-07 | us | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/BCSComponent | Breast Cancer Screening | active | 2025-08 | uv | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/HBPComponent | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | active | 2025-08 | uv | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/PVSComponent | Pneumococcal Vaccination Status for Older Adults | active | 2025-08 | uv | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/TSCComponent | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/BCSComponent | Breast Cancer Screening | active | 2022-02 | us | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/HBPComponent | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | active | 2022-02 | us | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/PVSComponent | Pneumococcal Vaccination Status for Older Adults | active | 2022-02 | us | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/TSCComponent | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | active | 2022-02 | us | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/CCSComponent | Cervical Cancer Screening | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/CCSComponent | Cervical Cancer Screening | active | 2022-02 | us | hl7 | ||
example.fhir.uv.mycontentig | R4 | Measure/HybridHospitalWideMortalityFHIRExample | Core Clinical Data Elements for the Hybrid Hospital-Wide (All-Condition, All-Procedure) Risk-Standardized Mortality Measure (HWM) FHIR Example | draft | 2025-08 | uv | hl7 | ||
gov.healthit.ecqi.ecqms.subset | R4 | Measure/HybridHospitalWideMortalityFHIR | Core Clinical Data Elements for the Hybrid Hospital Wide All Condition All Procedure Risk Standardized Mortality Measure HWMFHIR | active | 2024-09 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMSFHIR844HybridHospitalWideMortality | Core Clinical Data Elements HW Mortality FHIR | draft | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1218FHIRHHRF | Hospital Harm - Postoperative Respiratory FailureFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms.subset | R4 | Measure/HospitalHarmHyperglycemiainHospitalizedPatientsFHIR | Hospital Harm - Severe HyperglycemiaFHIR | active | 2024-09 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS871HHHyperFHIR | Hospital Harm - Severe HyperglycemiaFHIR | active | 2025-05 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS819FHIRHHORAE | Hospital Harm - Opioid-Related Adverse EventsFHIR | active | 2025-07 | ||||
hl7.fhir.uv.cqm | R4 | Measure/EXM108-FHIR | EXM108 - Venous Thromboembolism Prophylaxis | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/EXM108-FHIR | EXM108 - Venous Thromboembolism Prophylaxis | active | 2022-02 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS190VTEProphylaxisICUFHIR | Intensive Care Unit Venous Thromboembolism ProphylaxisFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS108FHIRVTEProphylaxis | Venous Thromboembolism ProphylaxisFHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS986FHIRMalnutritionScore | Malnutrition Care ScoreFHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms.subset | R4 | Measure/GlobalMalnutritionCompositeFHIR | Global Malnutrition Composite ScoreFHIR | active | 2024-09 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1244FHIRECATHOQR | Emergency Care Access & Timeliness (HOQR)FHIR | active | 2025-07 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1264FHIRECATREHQR | Emergency Care Access & Timeliness (REHQR)FHIR | active | 2025-07 | ||||
de.bbmri.fhir | R4 | Measure/PatientQualityReports | Patient Quality Reports | active | 2020-05 | ||||
de.bbmri.fhir | R4 | Measure/SpecimenQualityReports | Specimen Quality Reports | draft | 2020-05 | ||||
hl7.fhir.uv.saner | R4 | Measure/PatientsByRiskFactorWithSupplementalData | COVID-19 Patients By Risk Factor | draft | 2024-05 | uv | hl7 | ||
hl7.fhir.uv.saner | R4 | Measure/ComputableCDCPatientImpactAndHospitalCapacity | Patient Impact and Hospital Capacity | draft | 2024-05 | uv | hl7 | ||
hl7.fhir.uv.saner | R4 | Measure/FEMADailyHospitalCOVID19Reporting | FEMA Laboratory Orders and Results Daily Increase Reporting | draft | 2024-05 | uv | hl7 | ||
hl7.fhir.uv.saner | R4 | Measure/CDCPatientImpactAndHospitalCapacity | Patient Impact and Hospital Capacity | draft | 2024-05 | uv | hl7 | ||
hl7.fhir.uv.cqm | R4 | Measure/MultiRateExample-FHIR | Multi-Rate Example Measure | active | 2025-08 | uv | hl7 | ||
hl7.fhir.us.cqfmeasures | R4 | Measure/MultiRateExample-FHIR | Multi-Rate Example Measure | draft | 2022-02 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1206FHIRCTOQR | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Facility OQR FHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1056CTClinicalFHIR | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Clinician FHIR | active | 2025-06 | ||||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1074FHIRCTIQR | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Facility IQR FHIR | active | 2025-07 | ||||
hl7.fhir.us.safr | R4 | Measure/BedCapacityMeasure | Measure - Bed Capacity Measure Example | active | 2025-03 | us | hl7 | ||
gov.healthit.ecqi.ecqms | R4 | Measure/CMS1017FHIRHHFI | Hospital Harm – Falls with InjuryFHIR | active | 2025-07 | ||||
smart.who.int.hiv | R4 | Measure/HIVIND15 | HIV.IND.15 VMMC scale-up | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND4 | HIV.IND.4 Volume of PrEP prescribed | draft | 2024-08 | who | |||
hl7.fhir.us.safr | R4 | Measure/HrdMeasure | Hospital Respiratory Data Measure for US Situational Awareness Framework for Reporting | draft | 2024-12 | us | hl7 | ||
hl7.fhir.uv.cpg | R4 | Measure/chf-urine-out-measure | CHF Urine Out Metric | active | 2024-11 | uv | hl7 | ||
smart.who.int.hiv | R4 | Measure/HIVIND16 | HIV.IND.16 VMMC adverse events | draft | 2024-08 | who |